Clinical Trials Browser

Celecoxib × 30 days × Clear all

NCT06997068 2026-04-03

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population

Phase 2 Recruiting

Mouth Neoplasms

NCT02115074 2026-03-18

FLUVABREX

Phase 1 Completed

Glioma, Recurrence